May 17, 2022

Treace Benefits from Commercial Investments

Treace Benefits from Commercial Investments
The company grew more than 55% in 1Q22 on the strength of its narrow procedure focus and expanding direct sales force.
April 22, 2022

Globus Medical Reports CEO Transition

Globus Medical Reports CEO Transition
Dave Demski, President and CEO, resigned after nearly 20 years with the company. Daniel T. Scavilla has been named as his replacement, effective immediately.
April 21, 2022

LimaCorporate Appoints Interim CEO

LimaCorporate Appoints Interim CEO
Emmanuel Bonhomme will step in as Luigi Ferrari leaves to pursue new activities.
April 6, 2022

DJO Transitions Brand to Enovis

DJO Transitions Brand to Enovis
Enovis will stand as an entirely new public company solely focused on medical technology.
March 28, 2022

5 Market Opportunities for Small Orthopedic Companies

5 Market Opportunities for Small Orthopedic Companies
Companies set their sights on enabling technology, ASCs, personalized procedures and implants, registries and director-to-consumer marketing.
March 21, 2022

R&D Spend Just One Problem for Lagging Portfolios

R&D Spend Just One Problem for Lagging Portfolios
Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies.

Additive

March 16, 2022

DePuy Synthes Enhances the ATTUNE Knee Portfolio

DePuy Synthes Enhances the ATTUNE Knee Portfolio
The ATTUNE Cementless Fixed Bearing Knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized Knee are designed for more natural knee function.
March 14, 2022

Carbon22 Gains FDA 510(k) for Apollo Ankle Plates

Carbon22 Gains FDA 510(k) for Apollo Ankle Plates
Apollo Ankle Fracture Plating comprises see-through, ortholucent bone plates and screws used for orthopedic ankle fracture surgery.

Editor's Picks

March 28, 2022

5 Market Opportunities for Small Orthopedic Companies

5 Market Opportunities for Small Orthopedic Companies
Companies set their sights on enabling technology, ASCs, personalized procedures and implants, registries and director-to-consumer marketing.
March 23, 2022

Orthopedic Market Unlikely to Find Reprieve in 2022

Orthopedic Market Unlikely to Find Reprieve in 2022
Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022.
March 21, 2022

R&D Spend Just One Problem for Lagging Portfolios

R&D Spend Just One Problem for Lagging Portfolios
Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies.

Industry Voices

November 17, 2021

Exactech’s Retiring Founder and R&D Leader Shares Lessons Learned

Exactech’s Retiring Founder and R&D Leader Shares Lessons Learned
A few months ago, Gary Miller, Ph.D., gave a commencement speech to the University of Florida's graduating engineers. It was a fitting honor for a man who has dedicated decades to the field of engineering and was on the verge of a new chapter himself....

Surgeon Voices